Category Archives: Nanotechnology

ROCKVILLE, MD--(Marketwire -03/27/12)- MarketResearch.com has announced the addition of the new report "Nanotechnology for Drug Delivery: Global Market for Nanocarriers" to their collection of Biotechnology market reports. For more information, visit http://www.marketresearch.com/Cientifica-Ltd-v2574/Nanotechnology-Drug-Delivery-Global-Nanocarriers-6856624/

Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total addressable market. Liposomes will offer the largest addressable market ($15 billion) in 2021 while gold nanocarriers will see the highest compound annual growth rate (CAGR) -- 53.8% -- in the next decade.

Drugs are loaded into nanocarriers (also called nanoshells or nanoparticles, between 1 and 100 nm), then transported through the body to the target site. This kind of targeted drug delivery for the treatment of cancers is one of the most anticipated and discussed benefits of nanotechnology-enabled medicine as it offers a level of accuracy in delivering drugs that far surpasses present methods. Typically over 90% of a drug is wasted in the body, which leads to unwanted side effects. Modern chemotherapy bombards patients with drugs in the hope that tumorous cells will be destroyed. The lack of specificity of current drug delivery techniques mean patients' healthy cells are destroyed indiscriminately along with cancer cells.

Using nanotechnology to combat cancer is not new. Abraxane, the first nanoparticulate drug delivery product for the treatment of breast cancer, launched six years ago. There are now hundreds of new nanotech-based treatments under development, ranging from reformulation of existing drugs to enhance their efficacy to radical new "magic bullet" therapies.

The healthcare market is changing. We are seeing a paradigm shift away from blockbusters and a 'one-size fits all' approach to a more personalized medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become.

For more information, visit http://www.marketresearch.com/Cientifica-Ltd-v2574/Nanotechnology-Drug-Delivery-Global-Nanocarriers-6856624/

About MarketResearch.com

MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Veronica Franco at 240-747-3016 or visit MarketResearch.com.

Read the original post:
Market Research Forecasts Nanotechnology-Enabled Drug Delivery Market at $136 Billion by 2021

Dublin - Research and Markets (http://www.researchandmarkets.com/research/8f3c56b6/nanotechnology_mar) has announced the addition of the "Nanotechnology Market Forecast to 2014" report to their offering.

In the coming years, nanotechnology is set to play a pivotal role in various industry segments. The evolving technology has already influenced a large number of industrial segments, and the economic activity generated from it has been high in magnitude and wide in scope. The nanotechnology-based products, which have had a huge impact on almost each industrial sector, are now entering the consumer market in a big way.

As per the findings of our latest report, increased applications of the technology in sectors like electronics, cosmetics, and defense, would propel the growth of the global nanotechnology market, which is anticipated to expand at a CAGR of about 19% during 2011-2014.

According to Nanotechnology Market Forecast to 2014, electronic companies are finding new ways of incorporating nanotechnology into consumer products like music systems and mobile phones in order to improve their processing capabilities. Similarly, the technology could help improve cosmetics by changing their physical properties.

We also observed that the use of nanotechnology in defense technologies provides enhanced performance at lower cost. Besides, the budding technology has revolutionalized dental care as it decreases the healing time and improves the Osseo-integration during dental implant. Our report discusses in detail these application areas and the key market trends.

Though nanomaterials would continue to dominate the nanotechnology market in the coming years, nano devices, comprising nanolithographic tools for manufacturing the next generation semi-conductors, are estimated to grow at a much faster rate than nanomaterials in near future.

The crucial country-level analysis, included in the comprehensive research, identified that the US is the world's most prominent nanotechnology market and will continue to enjoy the biggest pie of the global industry in the years to come, despite developing economies like China, Korea, India, and Brazil investing huge sums in the nanotechnology R&D. Our report elaborates the application areas and regulatory environment relating to nanotechnology in these countries, along with the patent analysis.

Companies Mentioned:

- Altair Nanotechnologies Inc.

- Nanophase Technologies Corporation

Continue reading here:
Research and Markets: Nanotechnology Market Forecast to 2014

ESPOO, Finland & WATERVLIET, N.Y.--(BUSINESS WIRE)--

Vistec Lithography Inc. (www.vistec-semi.com) announced today that Micronova Nanofabrication Centre (www.micronova.fi) has selected one of its electron-beam lithography systems. The leading nanotechnology laboratory in Finland aims to use Vistecs EBPG5000plusES for the design, development and fabrication of micro- and nanosystems. The cutting edge technology is specialized for multi-user environments and is therefore a future-proof match to the needs of Micronova.

At Micronova more than 360 employees and students of different facilities carry out research in diverse fields of nanotechnology. The Finnish institute aims to use the system for research in the fields of nanoelectronics, nanofabrication, microelectronics, nanophotonics and microfabrication. This state-of-the-art electron-beam lithography system gives us the possibility to continue future-proof research at the very highest level. But not only the characteristics of the system determined our decision also the long term experience of Vistec in this field of research were decisive, comments Dr. Veli-Matti Airaksinen, director of Aalto Nanofab at Micronova, the acquisition of the new system.

The Vistec EBPG5000pES is a high-performance lithography tool based on reliable and well-proven system architecture. The system is equipped for true 100kV / 1mm performance under regular electron-optical conditions with a wide capability for high throughput applications. Rainer Schmid, General Manager Vistec Lithography, Inc., explains further characteristics: Its electron-optical column, rated for acceleration voltages of 50 and 100kV, enables the EBPG5000pES to provide a spot size down to <2.2nm. On the other hand nano-lithography structures smaller than 8nm can easily be generated. Furthermore the system incorporates an interactive graphical user interface (GUI). With this feature we enable the use for diverse, multiuser environments such as used at huge research institutes like Micronova or universities.

Micronova is one of the most scientific nano-research institutes in Europe. Therefore we are glad to have come to this agreement, comments Schmid the order. By providing a steady growing number of advanced research institutes and universities with electron-beam lithography systems Vistec has demonstrated that its technology is state-of-the-art and best choice. Vistec is known for its great support to its customers. But not only do our customers benefit from the cooperation, we do it as well. Having such a strong connection to cutting edge research institutes like Micronova enables us to continue the development of our technology to the demands of an even wider target group.

Micronova

Micronova Nanofabrication Centre is Finlands National Research Infrastructure for micro- and nanotechnology, jointly operated by Aalto University and VTT Technical Research Centre of Finland. Micronovas activities extend from fundamental physics to device prototyping, applied research and small-scale manufacturing. Technologies developed at Micronova include nanoelectronic and photonic devices, MEMS sensors, particle and X-ray detectors and THz technology.

Aalto University

Aalto University is a new multidisciplinary science and art community merging the strengths of three universities in the fields of science, technology, economics, art and design. Aalto University's cornerstones are its strengths in education and research, and its goal is to become one of the world's top universities. Aaltos community includes 20,000 students as well as a staff of 4,700 of which 340 are professors.

VTT Technical Research Centre of Finland

Read this article:
Finnish Research Centre Selects Cutting Edge Nanotechnology from Vistec

Dublin - Research and Markets (http://www.researchandmarkets.com/research/e0c7cab9/nanotechnology_in) has announced the addition of the "Nanotechnology in Health Care" book to their offering.

Nanotechnologies are among the fastest growing areas of scientific research, and this is expected to have a substantial impact on human health care, especially in biomedical applications and nanomedicine now and in the near future. In the present scenario, nanotechnology is spreading its wings to address the key problems in the field of nanomedicine and human health care by improving diagnosis, prevention, treatment, and tissue engineering.

This book provides an in-depth investigation of nanotechnology-based therapy and recent advancements in this field for revolutionizing the treatments for various fatal diseases, including cardiovascular and infectious diseases.

Key Features

- Covers significant applied aspects of nanotechnology with up-to-date information and its breakthrough in various fields of human health care

- Presents comprehensive coverage of the dominant technology in various aspects of human health, supported by excellent photographs, figures, and references

- Provides important information regarding a variety of topics that will influence improved nanomedicine and biomedical research

Readership

Advanced undergraduate- and graduate-level students in nanotechnology, nanobiotechnology; researchers in macromolecular science, nanosciences, nanotechnology, chemistry, biology, and medicine, especially those with an interest in drug delivery or cancer therapy.

Key Topics Covered:

See more here:
Research and Markets: Nanotechnology in Health Care. An In-Depth Investigation of Nanotechnology-Based Therapy

Nanotechnology and its use in drug development has been a growing area of investment in the U.S. and that growth has been mapped in an interactive infographic by the Project on Emerging Nanotechnologies.

The map lists nanotechnology companies and organizations across the country by specialties, such as medicine and health, materials, imaging and microscopy, electronics, tools and instruments, academic and government research, and associations.

Advertisement

The Philadelphia-based Nanotech Institute, formed by Ben Franklin Technology Partners of Southeastern Pennsylvania, along with Drexel University and University of Pennsylvania, received a reinvestment of $1.1 million from the Commonwealth. It is forging an alliance with another nanotechnology group in the western part of the state the Pennsylvania Nanomaterials Commercialization Center, which received $638,900 to assist small and startup companies with early stage prototype development projects.

Anthony P. Green, Ben Franklin director for the Nanotechnology Institute and vice president of technology commercialization in the life sciences for Ben Franklin, said in a statement that the number of company spinoffs, technology licenses and intellectual property assets have grown substantially in the past three years, exceeding the growth during the first 10 years of the institute. These activities are being reflected in real economic impact for the region in terms of job growth.

The Nanotechnology Institute has created more than 30 companies in the region, according to the statement, among them Keystone Nano, which has used nanotechnology to develop drug-delivery solutions for solid and nonsolid tumor cancers, and Leversense, which has developed a diagnostics platform.

Continued here:
Map illustrates scale of nanotechnology development across the U.S.

NAPLES, Fla.--(BUSINESS WIRE)--

Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanotechnology based energy saving and sustainable solutions announced today that the Co-Founders are retiring ninety percent of their Preferred Stock.

This is part of an overall strategy to structure Industrial Nanotech, Inc. for potential application to a more senior stock exchange, stated Stuart Burchill, Co-Founder and CEO/CTO of Industrial Nanotech, Inc. Based on revenue projections for the upcoming quarters, a result of eight years of diligent effort, it is appropriate to begin execution of a responsible strategy to provide maximum benefit to shareholder value. This is one step in that continuing process.

For further information on Nansulate nanotechnology based coatings and sustainable solutions visit: http://www.nansulate.com.

About Nansulate

Nansulate is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.inanotk.com) and (www.nansulate.com). Blog: http://www.nansulate.com/nanoblog, Twitter: http://www.twitter.com/NanoPioneer, Facebook: http://www.facebook.com/Nansulate.

About Industrial Nanotech Inc.

Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Green Building Council. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Read this article:
Industrial Nanotech, Inc. Founders Retiring 90% of Their Preferred Stock